Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

In mid-September 2024, a photo allegedly showing actor Keanu Reeves holding a pro-Trump T-shirt spread on social media. The item of clothing displayed variations of the slogan "NEVER STOP FIGHTING ...

The success of Eli Lilly & Co.'s weight-loss and diabetes drugs has pushed the company's stock to new heights, helping the founding family's endowment become the largest private foundation in the ...

You miss 100 percent of the shots you don’t take? Philadelphia Eagles cornerback and Super Bowl champion Eli Ricks learned that lesson in a pretty hilarious way — and got quite the surprise ...

The pharmaceutical giant has been racing against rivals such as Eli Lilly to dominate the highly lucrative weight-loss space. Morgan Stanley Research is projecting that the global market for ...

Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal focused on treating hearing loss. The centerpiece of the agreement is ...

As stated by Chelsea in their official launch, 'inspired by London's revolving energy, the 2025/26 home shirt features a textured clash print with our classic blue paired with a brighter shade ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best major stocks to buy according to billionaires. The U.S. stock market had one of the ...

The new 2025/26 home shirt looks a lot like the classic 1990/91 season’s shirt when Arsenal romped to a second First Division title in three years, losing just a single game on the way.

Eli Tsives went to UCLA to study and earn a degree. However, since Oct. 7, he has become more than just a student — he’s now also an activist and influencer. It wasn’t a role he planned to ...

Meanwhile, Eli Lilly's Zepbound injection has gained traction, prompting both firms to race toward more convenient weight?loss pills. Investors will watch upcoming trial readouts and regulatory ...